4 Results for "

KRAS inhibitor-18

" in MedChemExpress (MCE) Product Catalog:
Products (4)

4 Results for "KRAS inhibitor-18" in MCE Product Catalog:

Cat. No.: HY-146476
CAS No.: 2230873-66-0
Target:  

Ras

Research Areas:  

Cancer

KRAS inhibitor-18 (compound 3-10) is a potent KRAS G12C inhibitor with an IC50 of 4.74 µM. KRAS inhibitor-18 shows p-ERK inhibition activities with IC50s of 66.4, 11.1 µM in MIA PaCA-2, A549 cells, respectively. KRAS inhibitor-18 has the potential for the research of pancreatic, colorectal, and lung cancers .
loading...
    loading...
6
6 Cited Publications
Cat. No.: HY-156819
CAS No.: 3034802-05-3
Purity:  99.52%
Synonyms: RMC-9805; KRAS G12D inhibitor 18
Target:  

Ras Apoptosis

Research Areas:  

Cancer

Zoldonrasib (RMC-9805) is a potent and orally active KRAS G12D inhibitor.Zoldonrasib induces apoptosis in KRAS G12D mutant cancer cells. Zoldonrasib has the potential for the research of KRAS G12D mutant cancer .
loading...
    loading...
Cat. No.: HY-132979
CAS No.: 2649788-45-2
Target:  

Ras

Research Areas:  

Cancer

KRAS G12C inhibitor 18 is a potent and orally active KRAS G12C inhibitor. Anti-tumor activities .
loading...
    loading...
Cat. No.: HY-156819R
CAS No.: 3034802-05-3
Synonyms: RMC-9805 (Standard); KRAS G12D inhibitor 18 (Standard)
Research Areas:  

Cancer

Zoldonrasib (Standard) is the analytical standard of Zoldonrasib (HY-156819). This product is intended for research and analytical applications. Zoldonrasib (RMC-9805) is a potent and orally active KRAS G12D inhibitor.Zoldonrasib induces apoptosis in KRAS G12D mutant cancer cells. Zoldonrasib has the potential for the research of KRAS G12D mutant cancer .
loading...
    loading...